BackgroundPsoriasis impacts 1-3% of the world's population and is characterized by hyper-proliferation of keratinocytes and increased inflammation. At the molecular level, psoriasis is commonly driven by a Th17 response, which serves as a major therapeutic target. Microbiome perturbations have been associated with several immune-mediated diseases such as atopic dermatitis, asthma, and multiple sclerosis. Although a few studies have investigated the association between the skin microbiome and psoriasis, conflicting results have been reported plausibly due to the lack of standardized sampling and profiling protocols, or to inherent microbial variability across human subjects and underpowered studies. To better understand the link between the ...
Studies have shown differences in the skin and gut bacterial microbiomes in patients with psoriasis,...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...
Abstract Background Psoriasis impacts 1–3% of the world’s population and is characterized by hyper-p...
Summary Background The treatment of psoriasis has been revolutionized by the development of biologic...
Psoriasis is a chronic, immune-mediated inflammatory skin disease. Its pathogenesis is associated wi...
PurposeTo understand the changes in the microbiome in psoriatic disease, we conducted a systematic r...
Changes in the skin microbiome have been shown to promote cutaneous inflammation. The skin microbiom...
Background: Recent advances have highlighted the crucial role of microbiota in the pathophysiology o...
Psoriasis is a chronic noninfectious and inflammatory skin disease, whose pathogenesis involves envi...
Psoriasis is a chronic inflammatory skin disease associated with various factors. Recently, alterati...
Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder...
Psoriasis is an immune-mediated inflammatory skin disease that has been associated with cutaneous mi...
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indi...
Contains fulltext : 215275.pdf (publisher's version ) (Open Access)Despite recent ...
Studies have shown differences in the skin and gut bacterial microbiomes in patients with psoriasis,...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...
Abstract Background Psoriasis impacts 1–3% of the world’s population and is characterized by hyper-p...
Summary Background The treatment of psoriasis has been revolutionized by the development of biologic...
Psoriasis is a chronic, immune-mediated inflammatory skin disease. Its pathogenesis is associated wi...
PurposeTo understand the changes in the microbiome in psoriatic disease, we conducted a systematic r...
Changes in the skin microbiome have been shown to promote cutaneous inflammation. The skin microbiom...
Background: Recent advances have highlighted the crucial role of microbiota in the pathophysiology o...
Psoriasis is a chronic noninfectious and inflammatory skin disease, whose pathogenesis involves envi...
Psoriasis is a chronic inflammatory skin disease associated with various factors. Recently, alterati...
Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder...
Psoriasis is an immune-mediated inflammatory skin disease that has been associated with cutaneous mi...
Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indi...
Contains fulltext : 215275.pdf (publisher's version ) (Open Access)Despite recent ...
Studies have shown differences in the skin and gut bacterial microbiomes in patients with psoriasis,...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...
Evidence has shown that gut microbiome plays a role in modulating the development of diseases beyond...